Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Breast Care (Basel, Switzerland)|October 16, 2018
Late Administration of Trastuzumab Emtansine Might Lead to Loss of Chance for Better Outcome in Patients with HER2-Positive Metastatic Breast CancerLuis Manso, Alfonso Sanchez-Muñoz, Isabel Calvo, et al.
Critical Reviews in Oncology/Hematology|October 22, 2019
Targeted treatment approaches in refractory germ cell tumorsLaura Galvez-Carvajal, Alfonso Sanchez-Muñoz, Nuria Ribelles, et al.
Frontiers in Oncology|November 19, 2019
Deciphering HER2 Breast Cancer Disease: Biological and Clinical ImplicationsAna Godoy-Ortiz, Alfonso Sanchez-Muñoz, Maria Rosario Chica Parrado, et al.
Frontiers in Oncology|August 19, 2024
Role of poly-ADP-ribose polymerase inhibitors after brain progression in platinum-sensitive ovarian cancer: a case report and review of the literatureGonzalo Lendinez-Sanchez, Tamara Diaz-Redondo, Marcos Iglesias-Campos, et al.
International Journal of Oncology|October 19, 2012
Serum protein levels following surgery in breast cancer patients: a protein microarray approachLuis G Perez-Rivas, Jose M Jerez, Cristina E Fernandez-De Sousa, et al.
Breast Cancer Research : BCR|October 24, 2013
Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation indexNuria Ribelles, Lidia Perez-Villa, Jose Manuel Jerez, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2020
Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patientsNuria Ribelles, Jose M Jerez, Pablo Rodriguez-Brazzarola, et al.
Frontiers in Oncology|November 22, 2019
Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World DataTamara Díaz-Redondo, Rocio Lavado-Valenzuela, Begoña Jimenez, et al.
Journal of the National Cancer Institute|January 27, 2017
Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer PatientsEnrique Gonzalez-Billalabeitia, Daniel Castellano, Nora Sobrevilla, et al.
Pageof 1